Science & Research
Soligenix CEO Highlights Rare Disease Therapeutics and Public Health Solutions Strategy
Soligenix's CEO discusses the company's two-pronged business model focused on rare disease treatments and public health solutions, emphasizing significant government funding and promising clinical trial developments.
GeoVax Secures New Patent for Innovative Cancer Treatment Approach
GeoVax Labs has received a Notice of Allowance for a patent describing a novel triple-combination cancer therapy strategy targeting solid tumors with potential to minimize systemic toxicity and enhance treatment effectiveness.
Kairos Pharma to Showcase Oncology Research at D. Boral Capital Global Conference
Kairos Pharma will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its innovative cancer therapeutic research, focusing on overcoming drug resistance with its lead candidate ENV105.
University of Utah Researchers Develop AI Tool to Predict Disease Onset Years in Advance
Researchers have created RiskPath, an open-source AI platform capable of forecasting long-term health conditions before symptoms emerge, potentially revolutionizing preventive healthcare approaches.
Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk
A new study reveals that women with common autoimmune diseases like rheumatoid arthritis, lupus, and systemic sclerosis experience significantly higher cardiovascular disease-related mortality rates compared to men, highlighting critical gender disparities in health outcomes.
Study Reveals Pregnancy-Related Genes Contribute to Worse Lung Cancer Outcomes in Women
A new study from Memorial Sloan Kettering Cancer Center has uncovered how certain genes associated with pregnancy may negatively impact lung cancer survival rates in women, providing insights into potential future immune therapy developments.
Pacylex Pharmaceutical Explores N-myristoyltransferase Inhibitors as Potential ADC Cancer Therapies
Pacylex Pharmaceuticals is presenting innovative research on N-myristoyltransferase (NMT) inhibitors as potential payloads for antibody drug conjugates (ADCs), highlighting promising early clinical results in cancer treatment across multiple tumor types.
NanoViricides to Present at D. Boral Capital Inaugural Global Conference, Highlighting Antiviral Drug Development
NanoViricides, a clinical-stage biotech company specializing in nanomedicine-based antiviral treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its advanced drug candidates targeting respiratory viral infections and other diseases.
Soligenix's HyBryte Shows Promising Results in CTCL Treatment, Offering New Hope for Rare Skin Cancer Patients
Biotechnology company Soligenix has reported impressive interim results for HyBryte, a novel topical treatment for cutaneous T-cell lymphoma (CTCL), demonstrating a 75% response rate and potential to address a significant unmet medical need.
Geneticist Urges Bold Climate Action with Innovative CO2 Removal Strategies
Dr. David E. Comings calls on U.S. leaders to address the accelerating climate crisis by implementing scientifically-driven carbon removal technologies. His research highlights the urgent need for immediate intervention to reverse environmental damage.
Heart Failure Initiative Dramatically Increases Lifesaving Medication Use
A large-scale American Heart Association initiative has significantly improved the use of quadruple medical therapy for heart failure patients across U.S. hospitals, potentially reducing mortality rates and addressing treatment disparities.
GeoVax Advances COVID-19, Cancer, and Biosecurity Vaccine Platforms Despite BARDA Contract Setback
GeoVax Labs reports significant progress across multiple vaccine development programs, including a multi-antigen COVID-19 vaccine for immunocompromised patients, an oncology treatment for head and neck cancer, and a Mpox/smallpox vaccine addressing global biosecurity needs.
Soligenix Advances Treatment for Rare Skin Cancer with HyBryte™ Therapy
Soligenix's HyBryte™ therapy shows promise in treating early-stage cutaneous T-cell lymphoma, potentially addressing a significant gap in rare disease treatments within a rapidly growing global market.
TransCode Therapeutics Advances RNA Cancer Therapy in Phase 1a Trial, Shows Promising Early Results
TransCode Therapeutics reports encouraging progress in its Phase 1a trial of TTX-MC138, an RNA-based cancer therapy targeting microRNA-10b, with initial data suggesting potential effectiveness in treating metastatic tumors.
Scinai Immunotherapeutics to Discuss Potential Breakthrough Treatment for Rare Skin Disorders
Scinai Immunotherapeutics will host a webinar to explore the therapeutic potential of PC111, a novel monoclonal antibody targeting rare skin conditions like Pemphigus Vulgaris and SJS/TEN, following its recent acquisition of Pincell.
Rapid Diagnostic Test Developed for Bacterial Meningitis
Researchers at Amsterdam University Medical Center have created a new diagnostic test that can quickly and accurately detect bacterial meningitis by measuring protein levels in cerebrospinal fluid, potentially improving patient outcomes through faster diagnosis.
Free Online Masterclass Launches to Advance Signal Integrity Training for Electronics Engineers
The EEcosystem and Professor Dr. Eric Bogatin are offering a free online course, Transmission Lines 101, designed to fill critical gaps in engineering education by providing accessible, expert-level signal integrity training.
Pampa Metals Discovers New Copper-Gold Porphyry System in Argentina's San Juan Province
Pampa Metals has confirmed a significant new porphyry copper-gold discovery at its Piuquenes East project, with initial drilling revealing a multi-phase mineralization system that shows promising characteristics of world-class deposits.
Platinum Group Metals CEO Highlights Innovative Waterberg Project's Potential in Mining Podcast
Platinum Group Metals' leadership discusses the groundbreaking Waterberg Project in South Africa, showcasing a unique platinum and palladium deposit that promises more efficient and safer mining techniques compared to traditional operations.
Soligenix Advances HyBryte Therapy for Cutaneous T-Cell Lymphoma Treatment
Soligenix is progressing its phase 3 clinical trial for HyBryte, a novel photodynamic therapy targeting early-stage cutaneous T-cell lymphoma, with potential to provide a noninvasive and precise treatment option for patients.
GeoVax Presents Promising Clinical Data for Gedeptin® Gene Therapy in Head and Neck Cancer Treatment
GeoVax Labs revealed clinical trial results for Gedeptin®, a novel gene-directed prodrug therapy showing potential in treating advanced head and neck cancers with minimal side effects and stability in patient outcomes.
NanoViricides Advances Measles Drug Development with Promising Broad-Spectrum Antiviral
NanoViricides is developing NV-387, a broad-spectrum antiviral drug candidate targeting measles amid declining vaccination rates. The drug shows potential for addressing infectious disease challenges with its unique therapeutic approach.
Tonix Pharmaceuticals Reveals Promising Preclinical Data for Cancer Immunotherapy TNX-1700
Tonix Pharmaceuticals presented positive preclinical results for TNX-1700, a fusion protein showing potential in reducing immunosuppressive cells and enhancing anti-tumor immune responses in gastric cancer models, particularly when combined with anti-PD1 therapy.
Neutra Life Sciences Expands Clinical Research Network with Four New Specialized Medical Sites
Neutra Corp's subsidiary, Neutra Life Sciences, has rapidly expanded its clinical research capabilities by establishing joint venture partnerships with four specialized medical practices across diverse healthcare specialties. The strategic growth positions the company to support broader clinical research needs and accelerate medical innovation.
Canada Seeks Sovereign Space Launch Capabilities at Inaugural National Conference
Dr. Doug Milburn of Protocase will speak at the Canadian Space Launch Conference, highlighting the critical need for Canada to develop independent space launch capabilities in a rapidly expanding global space economy.
Annovis Bio Bolsters Neurodegenerative Research with Key Biostatistics Appointment
Annovis Bio strengthens its scientific team by appointing Hui Liu as Director of Biostatistics, enhancing its capabilities in clinical trial design and data analysis for neurodegenerative disease research.
Tevard Advances Promising tRNA Therapy for Duchenne Muscular Dystrophy
Tevard Biosciences reports breakthrough preclinical data demonstrating a novel suppressor tRNA therapy that successfully restored dystrophin protein and motor function in a Duchenne muscular dystrophy model, potentially offering hope for patients with nonsense mutations.
AHA Awards $1M to Study Cardiovascular Benefits of GLP-1 Medications Across Diverse Populations
The American Heart Association is funding seven research projects to investigate how GLP-1 medications impact cardiovascular health in different patient groups, with the goal of identifying who benefits most from these treatments and understanding variations in therapeutic response.
Golden Cariboo Resources Explores Advanced Gold Analysis Technique
Golden Cariboo Resources is pioneering a new non-destructive gold analysis method using PhotonAssay™ technology to improve sample accuracy and reduce potential measurement errors in mineral exploration.
Creative Biolabs Advances Antibody-Drug Conjugate Technology with Innovative Engineering Techniques
Creative Biolabs has made significant breakthroughs in antibody-drug conjugate (ADC) development, demonstrating advanced glycosylation engineering and innovative approaches to targeting cancer treatments through bispecific and antibody-oligonucleotide conjugates.